Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Thriva Solutions

Explore full profile

At-home blood testing for proactive health monitoring

London, United KingdomFounded 2015Biotech & Life Sciences
Valuation $10–25M Last recorded · 2020
Revenue $1–10M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Thriva Solutions and the history behind them.

About Thriva Solutions

Thriva is a health technology company providing at-home, finger-prick blood tests for proactive health management. Founded in 2015 by Hamish Grierson, Eliot Brooks, and Tom Livesey, the London-based startup was born from the founders' frustration with the reactive nature of traditional healthcare and the difficulty in obtaining preventative health insights. Grierson's personal interest in self-improvement and health, combined with his co-founders' experiences, revealed a gap in the market for accessible, understandable health tracking.

The company operates on a direct-to-consumer, subscription-based model, allowing users to regularly monitor various biomarkers from home. Customers order a testing kit online, collect a small blood sample, and send it to one of Thriva's UKAS-accredited partner labs for analysis. Within 48 hours, users receive their results on a personal online dashboard or mobile app, complete with a review from a qualified GP, personalized insights, and actionable advice to improve their health. The platform tracks results over time, helping users see the impact of lifestyle changes. Test packages range from essential checks like cholesterol and liver function to more advanced panels covering vitamins, diabetes risk, and hormone health.

In addition to its B2C service, Thriva has developed a B2B arm, Thriva Solutions, which partners with organizations like NHS trusts, insurers, private doctors, and clinical researchers to provide remote diagnostic services. This division expanded significantly during the COVID-19 pandemic, where the company supported large-scale national testing programs. Thriva has raised a total of $17.1M in funding from investors including Seedcamp, Target Global, and Pembroke VCT. The company has served over two million people and partnered with more than 700 organizations, demonstrating significant growth in the preventative health market.

Source: Dealroom company data

At a glance

Founded
2015
Headquarters
London, United Kingdom
Sector
Biotech & Life Sciences

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed6 investors entered at this stage

Series A3 investors entered at this stage

Team profiled 26 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇬🇧 United Kingdom88.1%
🇿🇦 South Africa7.1%
🇺🇸 United States2.4%
🇬🇷 Greece2.4%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Thriva Solutions on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Thriva Solutions on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.